IJROBP Journal SA-CME activity for January 1, 2021 provides practitioners with information to improve the informed consent process for both standard treatment and clinical trial enrollment.

IJROBP Journal SA-CME activity for December 1, 2020 provides practitioners some practical knowledge needed to counsel patients in the setting of various treatment regimens in the management of localized prostate carcinoma.

This journal activity provides practitioners with the knowledge about closing the practice gap in outlining safety concerns when MRI is integrated into radiation oncology departments.

IJROBP Journal SA-CME activity for November 15, 2020 provides practitioners some practical knowledge on the role of the immune system on tumor activity is an area of active research. Radiation therapy is one possible method of further modulating this response.

IJROBP Journal SA-CME activity for November 1, 2020 provides practitioners some practical knowledge about a hypofractionated regimen for small cell lung cancer that was found to have comparable survival and toxicity outcomes to conventionally fractionated radiotherapy.

IJROBP Journal SA-CME activity for October 1, 2020 provides practitioners with information regarding the combination of radiotherapy and modern checkpoint inhibition immunotherapy.

This journal activity provides practitioners with the knowledge about closing the practice gap in demonstrating, in a blinded fashion, the utility of chart rounds and the types of mistakes revealed and not revealed in radiation oncology chart rounds.

IJROBP Journal SA-CME activity for September 1, 2020 provides practitioners with information regarding the combination of radiotherapy and modern checkpoint inhibition immunotherapy.

IJROBP Journal SA-CME activity for August 1, 2020 provides practitioners with information regarding liquid biopsies such as circulating tumor cells, which are increasingly being incorporated in to clinical practice.

This journal activity provides practitioners with the knowledge regarding factors that may impact axillary dosimetry in the provision of tangential radiotherapy in the setting of limited or omitted axillary surgery.